These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33518672)

  • 21. Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse.
    Tahvili S; Törngren M; Holmberg D; Leanderson T; Ivars F
    PLoS One; 2018; 13(5):e0196598. PubMed ID: 29742113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Xenografts of porcine islets immunoprotected in hollow fibres reduce the incidence of diabetes in non-obese diabetic mice.
    Chaillous L; Darquy S; Maugendre S; Rivereau AS; Reach G; Saï P
    Diabetologia; 1996 May; 39(5):523-9. PubMed ID: 8739911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
    Bergerot I; Fabien N; Thivolet C
    Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Baclofen, a gamma-aminobutyric acid-b receptor agonist, delays diabetes onset in the non-obese diabetic mouse.
    Beales PE; Hawa M; Williams AJ; Albertini MC; Giorgini A; Pozzilli P
    Acta Diabetol; 1995 Mar; 32(1):53-6. PubMed ID: 7612919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sphingosine-1-Phosphate Receptor 1 Is Involved in Non-Obese Diabetic Mouse Thymocyte Migration Disorders.
    Lemos JP; Smaniotto S; Messias CV; Moreira OC; Cotta-de-Almeida V; Dardenne M; Savino W; Mendes-da-Cruz DA
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29757216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
    Reddy S; Young M; Poole CA; Ross JM
    Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of high-dose insulin treatment to increase beta-cell insulin content in diabetic non obese diabetic (NOD) mice.
    Bache I; Jørgensen KH; Buschard K
    Diabetes Res Clin Pract; 1997 Jul; 37(1):9-14. PubMed ID: 9279472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice].
    Liu F; Yu M; Zhu Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep; 34(5):281-3. PubMed ID: 11372396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69.
    Srinivasan S; Bolick DT; Lukashev D; Lappas C; Sitkovsky M; Lynch KR; Hedrick CC
    Diabetes; 2008 Feb; 57(2):484-93. PubMed ID: 18003758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of type I diabetes by low-dose gamma irradiation in NOD mice.
    Takahashi M; Kojima S; Yamaoka K; Niki E
    Radiat Res; 2000 Dec; 154(6):680-5. PubMed ID: 11096425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection from experimental autoimmune diabetes in the non-obese diabetic mouse with soluble interleukin-1 receptor.
    Nicoletti F; Di Marco R; Barcellini W; Magro G; Schorlemmer HU; Kurrle R; Lunetta M; Grasso S; Zaccone P; Meroni P
    Eur J Immunol; 1994 Aug; 24(8):1843-7. PubMed ID: 8056041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse.
    Calcinaro F; Dionisi S; Marinaro M; Candeloro P; Bonato V; Marzotti S; Corneli RB; Ferretti E; Gulino A; Grasso F; De Simone C; Di Mario U; Falorni A; Boirivant M; Dotta F
    Diabetologia; 2005 Aug; 48(8):1565-75. PubMed ID: 15986236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes.
    Augstein P; Elefanty AG; Allison J; Harrison LC
    Diabetologia; 1998 Nov; 41(11):1381-8. PubMed ID: 9833948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antioxidant MDL 29,311 prevents diabetes in nonobese diabetic and multiple low-dose STZ-injected mice.
    Heineke EW; Johnson MB; Dillberger JE; Robinson KM
    Diabetes; 1993 Dec; 42(12):1721-30. PubMed ID: 8243818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice.
    Stosic-Grujicic S; Cvetkovic I; Mangano K; Fresta M; Maksimovic-Ivanic D; Harhaji L; Popadic D; Momcilovic M; Miljkovic D; Kim J; Al-Abed Y; Nicoletti F
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1038-49. PubMed ID: 17148780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
    Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
    J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pertussigen treatment retards, but fails to prevent, the development of type I, insulin-dependent diabetes mellitus (IDDM) in NOD mice.
    Huang SW; Luchetta R; Peck AB
    Autoimmunity; 1991; 9(4):311-7. PubMed ID: 1954311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin does not alter diabetes incidence in the NOD mouse.
    Beales PE; Giorgini A; Annovazzi A; Signore A; Parlapiano C; Pozzilli P
    Horm Metab Res; 1997 Jun; 29(6):261-3. PubMed ID: 9230345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of oral insulin on the development of autoimmune diabetes in NOD mice fed a hypoallergenic diet.
    Shehadeh N; Weis R; Teninboum G; Benderly A; Etzioni A; Shamir R
    Diabetes Nutr Metab; 2004 Feb; 17(1):1-5. PubMed ID: 15163117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.